|Bid||6.74 x 1000|
|Ask||6.75 x 800|
|Day's range||6.01 - 6.85|
|52-week range||0.28 - 17.49|
|Beta (5Y monthly)||0.12|
|PE ratio (TTM)||N/A|
|Earnings date||12 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||09 Nov 2012|
|1y target est||17.67|
Aprea Therapeutics, Viking Therapeutics, and Vaxart could all generate life-changing returns for early shareholders.
Large-cap coronavirus vaccine stocks are making investors rich. Can this small biotech do so as well?
The tiny biotech's COVID-19 vaccine has generated excitement because it's a pill instead of a shot, which gives it a number of important advantages.